Avadel Pharmaceuticals (AVDL) Divestments: 2020-2021
Historic Divestments for Avadel Pharmaceuticals (AVDL) over the last 1 years, with Jun 2021 value amounting to $8.2 million.
- Avadel Pharmaceuticals' Divestments fell 43.10% to $8.2 million in Q2 2021 from the same period last year, while for Jun 2021 it was $27.5 million, marking a year-over-year change of. This contributed to the annual value of $16.5 million for FY2021, which is 35.29% down from last year.
- Per Avadel Pharmaceuticals' latest filing, its Divestments stood at $8.2 million for Q2 2021, which was down 0.00% from $8.2 million recorded in Q1 2021.
- Avadel Pharmaceuticals' Divestments' 5-year high stood at $14.5 million during Q2 2020, with a 5-year trough of $2.8 million in Q3 2020.
- Moreover, its 2-year median value for Divestments was $8.2 million (2021), whereas its average is $8.4 million.
- Data for Avadel Pharmaceuticals' Divestments shows a maximum YoY plummeted of 43.10% (in 2021) over the last 5 years.
- Quarterly analysis of 2 years shows Avadel Pharmaceuticals' Divestments stood at $8.2 million in 2020, then plummeted by 43.10% to $8.2 million in 2021.
- Its Divestments stands at $8.2 million for Q2 2021, versus $8.2 million for Q1 2021 and $8.2 million for Q4 2020.